Skip to content


Microscope lenses

Biomedical Institute for Multimorbidity

The Biomedical Institute for Multimorbidity (BIM) works to better understand integration between multiple chronic diseases to develop more effective prevention and treatment strategies.

The health challenge

As our population ages, multimorbidity – where someone has two or more long-term health conditions – becomes increasingly common. Multimorbidity reduces quality of life and is accelerated by deprivation, resulting in an increased burden on the NHS and the economy.

With the number of people aged 85 predicted to double in the next 20 years, multimorbidity will affect more people for longer, making it one of the biggest clinical challenges facing the NHS.

Care for people with multimorbidity is complex, as different conditions and their treatments interact in different ways. Despite this, multimorbidity is often managed through single disease-focused approaches – a disadvantage to the increasing proportion of patients with multiple, seemingly unrelated, diseases.

2 in 3 people over 65 years old suffer from two or more chronic conditions


How we are doing it

Effective diagnosis and treatment of multiple health conditions in an individual demands that research into diseases is integrated.

The Biomedical Institute for Multimorbidity encapsulates this integration strategy by bringing together researchers from a range of disciplines within our four main themes of biomedical research – Cancer Imaging; Cardiovascular and Haemostasis; Diabetes and Metabolism; Wound Healing and Respiratory – which are aligned to underpinning multimorbidity clusters and mechanisms.

Together, our interdisciplinary teams work in partnership with the Clinical Sciences Centre, Hull University Teaching Hospitals NHS Trust and industry partners, in order to deliver mechanistic and translational biomedical research.

Through these exciting research programmes, we also train talented early career scientists to become the next generation of biomedical researchers.


What we want to achieve

What causes multimorbidities

Discover new mechanisms responsible for specific multimorbidity disease clusters

Improve quality of life

Identify novel therapeutic approaches to inform personalised treatments

Train future experts

Train future generations of expert researchers to tackle multimorbidity

News in brief

Congratulations to our PhD students

Congratulations to Matthew Morfitt (supervised by Leonid Nikitenko and John Greenman), Shirin Hasan (supervised by Leonid Nikitenko and Anthony Maraveyas) and Olapeju Bolanle (supervised by Tim Palmer and Roger Sturmey) who all passed their PhD vivas subject to thesis corrections.

Professor Roger Sturmey chairs Regulating Stem Cell-based Embryo Models working group

Professor Roger Sturmey was invited to Chair the Guidelines Working Group for the Regulating Stem Cell-based Embryo Models (R-SCBEM) project. This is a group working to establish a voluntary national regulatory framework for the responsible use of stem-cell based embryo models.

Skin aging funding success

Congratulations to Dr Holly Wilkinson, who has secured £165,812 in industry funding to co-develop a novel treatment for skin ageing.


Biomedical Institute for Multimorbidity